News

Filter

Current filters:

Gilead SciencesHealthcare

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

18-04-2014

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

Brazil National Health System coverage of and access to HIV drugs

Brazil National Health System coverage of and access to HIV drugs

27-12-2013

Brazil’s National Health System (SUS) currently provides coverage for 22 drugs that are distributed…

AbbVieAnti-viralsAtriplaBrazilEvipleraGilead SciencesGlaxoSmithKlineHealthcareKaletra TabletsMarkets & MarketingPharmaceuticalSouth AmericaTriovirTruvadaViread

Biotech - the battle of branded drugs and generics

28-06-2010

With a string of patent protections expiring in the USA in 2010 onwards, many large pharmaceutical and…

Biogen IdecBiotechnologyGenericsGilead SciencesHealthcareMarkets & MarketingNorth AmericaPatents

Gilead Sciences to freeze and lower HIV drug prices to support AIDS Drug Assistance Programs

07-06-2010

USA-based Gilead Sciences and the ADAP Crisis Task Force (ACTF) have announced a series of initiatives…

Anti-viralsGilead SciencesHealthcareNorth AmericaPharmaceuticalPricing

Back to top